Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Enasidenib Mesylate

   Jazz Pharmaceuticals Ireland Limited

   Recurrent Acute Myeloid Leukemia

   phase 2 · small molecule · active

   1 trial →

2. Encorafenib + Binimetinib

   Regeneron UK Limited

   Melanoma BRAF V600E/K Mutated

   phase 2 · small molecule · active

   1 trial →

3. Endostar

   The First People's Hospital of Lianyungang

   Esophageal Cancer

   phase 2 · small molecule · active

   1 trial →

4. Endostar

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Nasopharyngeal Neoplasms

   phase 2 · small molecule · active

   2 trials →

5. Endostatins

   The First People's Hospital of Lianyungang

   Nasopharyngeal Carcinoma

   phase 2 · small molecule · active

   1 trial →

6. Enfortumab vedotin

   United Therapeutics Europe Ltd

   Metastatic Urothelial Carcinoma

   phase 2 · small molecule · active

   1 trial →

7. Engineered Mitochondrial Vaccine (IMP3-Mito)

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Head and Neck Squamous Cell Carcinoma

   phase 2 · mab · active

   1 trial →

8. Ensartinib

   The First People's Hospital of Lianyungang

   Solid Tumors

   phase 2 · small molecule · active

   1 trial →

9. Ensartinib

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Non-Small Cell Lung Cancer

   phase 2 · small molecule · active

   1 trial →

10. Entinostat

    Syndax Pharmaceuticals

    Melanoma

    phase 2 · small molecule · completed

    1 trial →

11. Entinostat

    Syndax Pharmaceuticals

    Non-Small-Cell Lung Carcinoma

    phase 2 · small molecule · completed

    1 trial →

12. Entinostat

    Syndax Pharmaceuticals

    Renal Cell Carcinoma

    phase 2 · small molecule · active

    2 trials →

13. Entinostat

    Syndax Pharmaceuticals

    Hodgkin's Lymphoma

    phase 2 · small molecule · terminated

    1 trial →

14. Entinostat

    Syndax Pharmaceuticals

    Non Small Cell Lung Cancer

    phase 2 · small molecule · terminated

    2 trials →

15. Entinostat

    Syndax Pharmaceuticals

    ER+ Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

16. Entinostat

    Syndax Pharmaceuticals

    Metastatic Cholangiocarcinoma

    phase 2 · small molecule · completed

    1 trial →

17. Entinostat

    Syndax Pharmaceuticals

    Lymphoma

    phase 2 · small molecule · active

    1 trial →

18. Entinostat

    KYOWA KIRIN AUSTRALIA PTY LTD

    Advanced or Recurrent Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

19. Entrectinib

    Hoffmann-La Roche

    Solid Tumors

    phase 2 · small molecule · active

    1 trial →

20. Entrectinib

    Hoffmann-La Roche

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

21. Envafolimab

    The First People's Hospital of Lianyungang

    Metastatic Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

22. Envafolimab

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 2 · small molecule · active

    1 trial →

23. Envafolimab Injection

    The First People's Hospital of Lianyungang

    Gastrointestinal Neoplasms

    phase 2 · small molecule · active

    1 trial →

24. Enzalutamide

    CORCEPT THERAPEUTICS INC

    Metastatic Breast Cancer

    phase 2 · small molecule · active

    1 trial →

25. Enzalutamide

    BRIGHT MINDS BIOSCIENCES INC.

    Prostate Cancer Metastatic

    phase 2 · small molecule · completed

    1 trial →

26. Enzalutamide 40mg

    United Therapeutics Europe Ltd

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    phase 2 · small molecule · active

    1 trial →

27. Epcoritamab

    ADC Therapeutics SA

    Large B-cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

28. Epcoritamab

    United Therapeutics Europe Ltd

    Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

    phase 2 · mab · active

    1 trial →

29. Epcoritamab for DIFFUSE LARGE B CELL LYMPHOMA

    Genmab A/S

    DIFFUSE LARGE B CELL LYMPHOMA

    phase 2 · small molecule · active

    1 trial →

30. Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs)

    Evidence Based Cataract Study Group

    EBV-induced Lymphomas

    phase 2 · mab · completed

    1 trial →

31. Erdafitinib Intravesical Delivery System

    Janssen Cilag International NV

    Non-Muscle Invasive Bladder Neoplasms

    phase 2 · small molecule · active

    1 trial →

32. Eribulin mesylate

    HALOZYME THERAPEUTICS, INC.

    Metastatic Breast Cancer

    phase 2 · small molecule · terminated

    1 trial →

33. Erlotinib

    Hoffmann-La Roche

    Pancreatic Cancer

    phase 2 · small molecule · completed

    1 trial →

34. Erlotinib

    Solid Biosciences

    Leptomeningeal Carcinomatosis

    phase 2 · small molecule · terminated

    1 trial →

35. Erlotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small-cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

36. Erlotinib

    Hoffmann-La Roche

    Non-Small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

37. Erlotinib

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

38. Erlotinib

    United Therapeutics Europe Ltd

    Non-Small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

39. Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)

    Jazz Pharmaceuticals Ireland Limited

    Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

    phase 2 · small molecule · terminated

    1 trial →

40. Etigilimab

    Mereo BioPharma Group plc

    Solid Tumor, Adult

    phase 2 · small molecule · completed

    1 trial →

41. Etoposide

    The First People's Hospital of Lianyungang

    Small Cell Lung Cancer Limited Stage

    phase 2 · small molecule · active

    1 trial →

42. Etrumadenant

    Arcus Biosciences

    Prostatic Neoplasms, Castration-Resistant

    phase 2 · small molecule · completed

    1 trial →

43. Etrumadenant (AB928)

    Arcus Biosciences

    Rectal Cancer

    phase 2 · small molecule · active

    1 trial →

44. Everolimus

    Takeda

    Clear-cell Metastatic Renal Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

45. Evorpacept (ALX148)

    ALX ONCOLOGY HOLDINGS INC

    Breast Cancer, Metastatic

    phase 2 · small molecule · active

    1 trial →

46. Evorpacept (ALX148)

    ALX ONCOLOGY HOLDINGS INC

    Microsatellite Stable Metastatic Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

47. Exercise Training

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 · other · completed

    1 trial →

48. Exicorilant

    CORCEPT THERAPEUTICS INC

    Metastatic Castration-Resistant Prostate Cancer

    phase 2 · small molecule · terminated

    1 trial →

Frequently asked questions